These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3688805)

  • 1. The significance of Candida-specific serum IgE in recurrent vaginal candidiasis.
    Ratnam KV; Lee CT; Wong TW
    Ann Acad Med Singap; 1987 Apr; 16(2):306-9. PubMed ID: 3688805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis.
    Regúlez P; García Fernández JF; Moragues MD; Schneider J; Quindós G; Pontón J
    Gynecol Obstet Invest; 1994; 37(2):110-4. PubMed ID: 8150365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of interleukins and of Candida-IgE in chronic recurrent vulvovaginal candidosis].
    Weissenbacher ER; Weissenbacher T; Spitzbart H
    Mycoses; 2004; 47 Suppl 1():37-40. PubMed ID: 15667363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis].
    de Carvalho RJ; Cunha CM; Silva DA; Sopelete MC; Urzedo JE; Moreira TA; Moraes Pde S; Taketomi EA
    Rev Assoc Med Bras (1992); 2003; 49(4):434-8. PubMed ID: 14963598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total and Candida - Specific IgE in Recurrent Vaginal Candidiasis.
    Ratnam KV; Lee CT; Wong TW
    Indian J Dermatol Venereol Leprol; 1987; 53(3):164-167. PubMed ID: 28145328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid.
    Weissenbacher TM; Witkin SS; Gingelmaier A; Scholz C; Friese K; Mylonas I
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):59-63. PubMed ID: 19261373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between atopy and recurrent vaginal candidiasis.
    Neves NA; Carvalho LP; De Oliveira MA; Giraldo PC; Bacellar O; Cruz AA; Carvalho EM
    Clin Exp Immunol; 2005 Oct; 142(1):167-71. PubMed ID: 16178872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.
    Witkin SS; Jeremias J; Ledger WJ
    J Med Vet Mycol; 1989; 27(1):57-8. PubMed ID: 2666634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A localized vaginal allergic response in women with recurrent vaginitis.
    Witkin SS; Jeremias J; Ledger WJ
    J Allergy Clin Immunol; 1988 Feb; 81(2):412-6. PubMed ID: 3422256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of in vivo and in vitro IgA coating of candida species in vulvovaginal candidiasis.
    Böhler K; Klade H; Poitschek C; Reinthaller A
    Genitourin Med; 1994 Jun; 70(3):182-6. PubMed ID: 8039782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eosinophilia in peripheral blood of women with recurrent vaginal candidiasis].
    Queiroz Filho J; Gonçalves AK; Cavalcante GB; Pessoa DC; Eleutério J; Giraldo PC; Sales VS
    Rev Bras Ginecol Obstet; 2013 Oct; 35(10):453-7. PubMed ID: 24337057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity in vaginal candidiasis.
    Fidel PL
    Curr Opin Infect Dis; 2005 Apr; 18(2):107-11. PubMed ID: 15735412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
    Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
    Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin class of anti-Candida antibodies in patients with vaginal candidiasis.
    Burges G; Holley HP; Virella G
    Diagn Immunol; 1986; 4(1):43-6. PubMed ID: 3514071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
    Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
    Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal vaccination induces the ability to eliminate Candida colonization without influencing the pre-existing antigen-specific IgE Abs: a possibility for the control of Candida-related atopic dermatitis.
    Suenobu N; Kweon MN; Kiyono H
    Vaccine; 2002 Jul; 20(23-24):2972-80. PubMed ID: 12126910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent vulvovaginal candidiasis: why does it occur?
    Rodgers CA; Beardall AJ
    Int J STD AIDS; 1999 Jul; 10(7):435-9; quiz 440-1. PubMed ID: 10454177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on the relationship between vaginal and intestinal candida in patients with vulvovaginal candidiasis].
    Lin XL; Li Z; Zuo XL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):496-500. PubMed ID: 22041440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle.
    Fidel PL; Barousse M; Lounev V; Espinosa T; Chesson RR; Dunlap K
    Med Mycol; 2003 Apr; 41(2):97-109. PubMed ID: 12964841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin classes of human serum antibodies in vaginal candidiasis.
    Warnock DW; Milne JD; Fielding AM
    Mycopathologia; 1978 Aug; 63(3):173-5. PubMed ID: 357978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.